Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
441 | 26474 | 44.3 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
441 | 3 | TRAIL//SURVIVIN//APOPTOSIS | 26474 |
306 | 2 | TRAIL//SURVIVIN//APOPTOSIS | 18497 |
2106 | 2 | GAS6//AXL//MFG E8 | 5138 |
3417 | 2 | DEOXYRIBONUCLEASE I//MED GENET BIOCHEM//DEOXYRIBONUCLEASE | 1582 |
3606 | 2 | TRIPTOLIDE//CELASTROL//PDCD5 | 1257 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TRAIL | authKW | 792149 | 4% | 58% | 1179 |
2 | SURVIVIN | authKW | 747484 | 4% | 56% | 1151 |
3 | APOPTOSIS | authKW | 741830 | 30% | 8% | 7957 |
4 | TRIPTOLIDE | authKW | 338487 | 1% | 81% | 365 |
5 | FAS | authKW | 245866 | 3% | 29% | 737 |
6 | NECROPTOSIS | authKW | 212318 | 1% | 65% | 284 |
7 | CASPASE | authKW | 183361 | 4% | 15% | 1054 |
8 | BCL 2 | authKW | 169868 | 4% | 14% | 1052 |
9 | DEATH RECEPTOR | authKW | 165575 | 1% | 49% | 294 |
10 | CELL DEATH AND DIFFERENTIATION | journal | 144717 | 2% | 20% | 632 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 56009 | 25% | 1% | 6521 |
2 | Oncology | 50910 | 24% | 1% | 6347 |
3 | Biochemistry & Molecular Biology | 29699 | 30% | 0% | 8044 |
4 | Immunology | 8885 | 10% | 0% | 2774 |
5 | Hematology | 5170 | 5% | 0% | 1338 |
6 | Medicine, Research & Experimental | 4465 | 6% | 0% | 1587 |
7 | Biophysics | 2849 | 5% | 0% | 1288 |
8 | Pathology | 1811 | 3% | 0% | 807 |
9 | Genetics & Heredity | 1498 | 5% | 0% | 1221 |
10 | Chemistry, Medicinal | 765 | 2% | 0% | 634 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPT CANC PEDIAT | 55645 | 0% | 61% | 79 |
2 | PROGRAM OPTOSIS CELL DEATH | 39661 | 0% | 49% | 70 |
3 | OPTOSIS REGULAT | 21254 | 0% | 60% | 31 |
4 | MED GENET BIOCHEM | 20703 | 0% | 49% | 37 |
5 | CELL CLEARANCE | 15861 | 0% | 53% | 26 |
6 | TUMOR IMMUNOL PROGRAM | 15312 | 0% | 21% | 64 |
7 | PATTERN RECOGNIT RECEPTOR DISCOVERY PERFORMANCE U | 14836 | 0% | 56% | 23 |
8 | IMMUNOL | 14377 | 4% | 1% | 1053 |
9 | PATHOL | 14030 | 10% | 1% | 2566 |
10 | MED | 13367 | 27% | 0% | 7068 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELL DEATH AND DIFFERENTIATION | 144717 | 2% | 20% | 632 |
2 | PEZCOLLER FOUNDATION SYMPOSIA | 68628 | 1% | 17% | 348 |
3 | CELL DEATH & DISEASE | 26603 | 1% | 10% | 235 |
4 | ONCOGENE | 13978 | 2% | 3% | 481 |
5 | MOLECULAR CANCER THERAPEUTICS | 8267 | 1% | 4% | 174 |
6 | JOURNAL OF BIOLOGICAL CHEMISTRY | 6905 | 4% | 1% | 1060 |
7 | CANCER RESEARCH | 6465 | 2% | 1% | 497 |
8 | CANCER BIOLOGY & THERAPY | 5794 | 0% | 4% | 121 |
9 | CLINICAL CANCER RESEARCH | 5769 | 1% | 2% | 284 |
10 | INTERNATIONAL JOURNAL OF ONCOLOGY | 5675 | 1% | 2% | 224 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRAIL | 792149 | 4% | 58% | 1179 | Search TRAIL | Search TRAIL |
2 | SURVIVIN | 747484 | 4% | 56% | 1151 | Search SURVIVIN | Search SURVIVIN |
3 | APOPTOSIS | 741830 | 30% | 8% | 7957 | Search APOPTOSIS | Search APOPTOSIS |
4 | TRIPTOLIDE | 338487 | 1% | 81% | 365 | Search TRIPTOLIDE | Search TRIPTOLIDE |
5 | FAS | 245866 | 3% | 29% | 737 | Search FAS | Search FAS |
6 | NECROPTOSIS | 212318 | 1% | 65% | 284 | Search NECROPTOSIS | Search NECROPTOSIS |
7 | CASPASE | 183361 | 4% | 15% | 1054 | Search CASPASE | Search CASPASE |
8 | BCL 2 | 169868 | 4% | 14% | 1052 | Search BCL+2 | Search BCL+2 |
9 | DEATH RECEPTOR | 165575 | 1% | 49% | 294 | Search DEATH+RECEPTOR | Search DEATH+RECEPTOR |
10 | MCL 1 | 131664 | 1% | 43% | 267 | Search MCL+1 | Search MCL+1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CZABOTAR, PE , LESSENE, G , STRASSER, A , ADAMS, JM , (2014) CONTROL OF APOPTOSIS BY THE BCL-2 PROTEIN FAMILY: IMPLICATIONS FOR PHYSIOLOGY AND THERAPY.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 15. ISSUE 1. P. 49 -63 | 178 | 84% | 433 |
2 | YOULE, RJ , STRASSER, A , (2008) THE BCL-2 PROTEIN FAMILY: OPPOSING ACTIVITIES THAT MEDIATE CELL DEATH.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 9. ISSUE 1. P. 47 -59 | 123 | 76% | 2030 |
3 | FULDA, S , VUCIC, D , (2012) TARGETING IAP PROTEINS FOR THERAPEUTIC INTERVENTION IN CANCER.NATURE REVIEWS DRUG DISCOVERY. VOL. 11. ISSUE 2. P. 109 -124 | 179 | 80% | 235 |
4 | GALLUZZI, L , BRAVO-SAN PEDRO, JM , VITALE, I , AARONSON, SA , ABRAMS, JM , ADAM, D , ALNEMRI, ES , ALTUCCI, L , ANDREWS, D , ANNICCHIARICO-PETRUZZELLI, M , ET AL (2015) ESSENTIAL VERSUS ACCESSORY ASPECTS OF CELL DEATH: RECOMMENDATIONS OF THE NCCD 2015.CELL DEATH AND DIFFERENTIATION. VOL. 22. ISSUE 1. P. 58 -73 | 171 | 55% | 147 |
5 | DE MIGUEL, D , LEMKE, J , ANEL, A , WALCZAK, H , MARTINEZ-LOSTAO, L , (2016) ONTO BETTER TRAILS FOR CANCER TREATMENT.CELL DEATH AND DIFFERENTIATION. VOL. 23. ISSUE 5. P. 733 -747 | 166 | 83% | 10 |
6 | EARNSHAW, WC , MARTINS, LM , KAUFMANN, SH , (1999) MAMMALIAN CASPASES: STRUCTURE, ACTIVATION, SUBSTRATES, AND FUNCTIONS DURING APOPTOSIS.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 68. ISSUE . P. 383 -424 | 221 | 59% | 1865 |
7 | JOHNSTONE, RW , FREW, AJ , SMYTH, MJ , (2008) THE TRAIL APOPTOTIC PATHWAY IN CANCER ONSET, PROGRESSION AND THERAPY.NATURE REVIEWS CANCER. VOL. 8. ISSUE 10. P. 782 -798 | 165 | 85% | 462 |
8 | COHEN, GM , (1997) CASPASES: THE EXECUTIONERS OF APOPTOSIS.BIOCHEMICAL JOURNAL. VOL. 326. ISSUE . P. 1-16 | 121 | 79% | 3218 |
9 | PASPARAKIS, M , VANDENABEELE, P , (2015) NECROPTOSIS AND ITS ROLE IN INFLAMMATION.NATURE. VOL. 517. ISSUE 7534. P. 311 -320 | 99 | 82% | 135 |
10 | LEMKE, J , VON KARSTEDT, S , ZINNGREBE, J , WALCZAK, H , (2014) GETTING TRAIL BACK ON TRACK FOR CANCER THERAPY.CELL DEATH AND DIFFERENTIATION. VOL. 21. ISSUE 9. P. 1350 -1364 | 134 | 88% | 100 |
Classes with closest relation at Level 3 |